JHOULEEN ANGELIKA TIAMZON: Open Payments
NPI 1306451471 · LAS VEGAS, NV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,579 in 110 payments from 18 companies in 2025. Trend: 2023 $1,373 · 2024 $2,604 · 2025 $2,579
Food & beverage: $2,572Education: $6
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 17 | $377 |
| Travere Therapeutics, Inc. | 9 | $310 |
| Novartis Pharmaceuticals Corporation | 12 | $287 |
| Amgen Inc. | 10 | $258 |
| Bayer Healthcare Pharmaceuticals Inc. | 10 | $229 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 7 | $175 |
| Vifor Pharma, Inc. | 11 | $169 |
| Calliditas Therapeutics US Inc. | 7 | $169 |
| ANI Pharmaceuticals, Inc. | 7 | $143 |
| AKEBIA THERAPEUTICS INC | 4 | $104 |
Products named: Fabhalta, KRYSTEXXA, Kerendia, JYNARQUE, JARDIANCE, Veltassa, TARPEYO, PURIFIED CORTROPHIN GEL.
Industry payments across NV — which companies pay providers there.
